Headlands Technologies »

Cytokinetics shares owned by Headlands Technologies

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Headlands Technologies from 13F filings

Historical chart of Headlands Technologies investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Headlands Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Headlands Technologies

Quarter filed Position value Share count Share price at filing
2023-12-31 $877k 11k 83.49

More positions owned by Headlands Technologies

NVIDIA Corporation (NVDA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
Microsoft Corporation (MSFT)
Linde SHS (LIN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vale S A Sponsored Ads (VALE)
Asml Holding N V N Y Registry Shs (ASML)
Rio Tinto Sponsored Adr (RIO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Applied Materials (AMAT)
Petroleo Brasileiro Sa Petro Sponsored Adr (PBR)
Broadcom (AVGO)
At&t (T)
Verisign (VRSN)

View all positions for Headlands Technologies

Top funds holding Cytokinetics

Vanguard Group
Wellington Management Company
Caption Management
T. Rowe Price Associates
Henderson Group
Boxer Capital
Citadel Advisors
Partner Fund Management
Logos Global Management
Lord, Abbett & Co
Millennium Management
Artal Group
Barclays
Gts Securities
Goldman Sachs Group

View all funds holding Cytokinetics